Covid-19 and road fragility
In response to Covid-19 social-health emergency, MAGIS supports a project of screening, research and medical assistance to the homeless population of Rome.
In the face of Coronavirus epidemic in Italy, MAGIS has chosen to support a project (from 25 May to 25 July) of prevention, diagnosis and treatment in favour of research and the population living in conditions of particular vulnerability and social exclusion in the city of Rome.
The project’s general objective is to ensure the early detection of positive COVID19 cases and their inclusion in specific diagnosis and treatment pathways.
The specific objectives are to improve knowledge about the immune response of Covid-19, to support the activity of monitoring and medical assistance of the population by identifying serologically positive subjects and contacts, and to implement an epidemiological investigation in order to identify the rate of spread of the virus and the penetration of clusters of infection.
MAGIS’ local partners are the Covid-2019 Research Centre of Tor Vergata University of Rome (which offers its laboratories and staff for the analysis of samples and diagnostic research), the Associazione Medicina Solidale (which makes available one of its outpatient clinics where screening for fragile people can be carried out) and INTERSOS (which is active with two mobile health units which carry out shifts of health education and medical examinations).
1,000 homeless people are expected to be directly involved in the project.
People turning to Medicina Solidale outpatient clinic and to INTERSOS mobile units undergo medical examinations aimed at assessing the risk of COVID19 and receive all information on prevention and reduction of the risk of infection.
People with symptoms are proposed to undergo (after informed consent) a rapid serological test. If the test is positive, the blood sample is analysed by Covid Laboratory for confirmation and quantification of the antibody titer. Homeless positive people are hosted in a protected facility for fiduciary isolation.
A survey is conducted to identify and include in the study all the contacts of the people found to be positive. Positive people are invited to participate, following informed consent, in a follow-up study aimed at understanding the existence of immunological memory (antibody titer and duration) and possible protection from secondary infections. Finally, a bimonthly scientific and epidemiological report is drawn up.